Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
06/2001
06/20/2001CN1067389C Benzodihydropyran assorbic acid derivatives, their preparation and use
06/19/2001CA2028048C Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol
06/14/2001WO2001042231A2 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
06/14/2001WO2001042179A1 Compounds which mimic the chemical and biological properties of discodermolide
06/14/2001WO2001009113A3 Heterocyclic compounds inhibiting angiogenesis
06/14/2001CA2393968A1 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2001EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
06/13/2001EP1105376A1 Oxindole derivatives as growth hormone releasers
06/13/2001EP1105120A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
06/13/2001CN1299359A Benzofurylpyrone derivatives
06/13/2001CN1298877A Tacca chantrieri andre ketonic internal ester and its use
06/12/2001US6245745 Bactericides and antiprotozoa agents
06/07/2001WO2001040256A1 Taccalonolides and their use
06/07/2001WO2001040187A2 Compound having effect of promoting neuron differentiation
06/07/2001CA2388239A1 Neuroprotective agents and methods related thereto
06/06/2001EP1104416A2 Quaternary ammonium salts and their use as anti-hiv agents
06/06/2001CN1066625C Therapeutical use for benzopyran derivative
06/05/2001US6242616 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
06/05/2001US6242582 Method of detection of influenza virus and compounds for use therein
05/2001
05/31/2001WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/31/2001US20010002423 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound
05/31/2001CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
05/30/2001EP1103548A1 Triazolone derivatives, use thereof, and intermediate therefor
05/30/2001EP1102761A2 Cyclopentabenzofuran derivatives and their use
05/30/2001EP0861242B1 Heterocyclic fungicides
05/29/2001US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents
05/29/2001US6239151 Compounds as inhibitor of tumor necrosis factor alpha release
05/29/2001CA2035024C Novel glyoxylates and herbicidal and plant growth regulant activity of glyoxylates
05/23/2001EP0788497B1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
05/23/2001CN1296047A Solidifiable compositions
05/17/2001WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/17/2001WO2001014358A3 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
05/16/2001EP1099730A1 Curable composition
05/16/2001EP1098893A1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
05/16/2001CN1295571A PDE IV inhibiting pyridine derivatives
05/16/2001CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof
05/16/2001CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor
05/10/2001WO2001032654A2 Novel heterocyclic compounds and their use as medicines
05/10/2001WO2001032619A1 Positive modulators of nicotinic receptor agonists
05/10/2001CA2387745A1 Positive modulators of nicotinic receptor agonists
05/10/2001CA2325271A1 Curable composition
05/08/2001US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups
05/03/2001WO2001030795A1 Hygromycin derivatives
05/03/2001WO2001030776A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same
05/03/2001CA2389191A1 Hygromycin derivatives
05/03/2001CA2389169A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same
05/02/2001EP1095947A1 Novel antibacterial compounds
05/02/2001EP1095938A1 Oxetane compounds, oxetane copolymer, and process for producing oxetane compounds
05/02/2001EP1078926A9 Pyran derivatives
05/02/2001CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them
05/01/2001US6225479 Optically active bis-dioxane derivatives
05/01/2001US6225478 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
05/01/2001US6225312 Piperazine and piperidine compounds
04/2001
04/26/2001WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators
04/26/2001WO2001029023A1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
04/26/2001WO2001028996A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones
04/26/2001CA2388859A1 Inhibitors of neuraminidases
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators
04/24/2001US6222048 Diaryl-2-(5H)-furanones as Cox-2 inhibitors
04/24/2001US6221637 Immunomodulators for treating graft rejection, or nephritis; inhibits signal transduction by t-cells; methyl 2-(carboxymethylsulfinyl)-5,7-dichloro-3,8-dihydroxy-6-methyl-9-oxo-9h -xanthene-1-carboxylate, for example
04/18/2001EP0682663B1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections
04/17/2001US6218431 Substituted biphenyls
04/17/2001US6218427 Chromene-3-carboxylate derivatives
04/17/2001US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated
04/17/2001US6218369 Administering flavanolignane selected from silymarin, silybin, silidianin, silicristin, dehydrosilybin, phospholipid complex of one of these flavanolignanes, and mixtures, in combination with antitumor agent
04/12/2001WO2001025220A1 Triazine kinase inhibitors
04/12/2001CA2386218A1 Triazine kinase inhibitors
04/11/2001EP1089998A2 Epothilone derivatives and their synthesis and use
04/11/2001EP1089964A1 Hydrazine derivatives
04/11/2001EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
04/11/2001CN1291192A 5,6,7-trino-4,8-inter-m-phenylene PGI2 derivative and drugs containing the same
04/11/2001CN1064354C Trilcyclic benzazepine vasopressin antagnonists
04/10/2001US6215016 Hematopoietic agents; preventing cytopenia
04/10/2001US6215007 Recombinant production of novel polyketides
04/10/2001US6214996 Naphthalene derivates, process for the preparation thereof, and intermediates therefor
04/10/2001US6214870 Antiarthritic agents; anticancer agents
04/10/2001US6214573 Recombinant production of novel polyketides
04/04/2001EP1087959A1 Novel benzopyran or thiobenzopyran derivatives
04/04/2001EP1087948A1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
04/04/2001EP1087780A1 Extraction method, pharmaceutical composition and a cosmetic composition
04/04/2001EP0636127B1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
04/04/2001CN1290264A Triazine angiogenesis inhibitors
04/03/2001US6211201 Multivalent salts of pyridostigmine and related compounds
03/2001
03/28/2001EP1086950A1 Heterocyclic indole derivatives and mono- or diazaindole derivatives
03/28/2001EP1086076A1 Sulfonamide inhibitors of aspartyl protease
03/28/2001CN1063748C Naphthalene derivatives, process for preparation thereof and intermediates thereof
03/27/2001US6207841 Bisphenol derivative and its manufacturing method
03/27/2001US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia
03/21/2001CN1063439C N-substituted 2-hetero cyclicbutanol
03/15/2001WO2000075127A8 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
03/15/2001WO1999065870A3 Sulfonamide inhibitors of aspartyl protease
03/13/2001US6201140 7-0-ethers of taxane derivatives
03/13/2001US6201135 Method for separating contaminants from 3-(2′-Acetoxy-Ethyl-Dihydro-2(3H)-Furanone
03/07/2001CN1286686A Taxane derivs
03/07/2001CN1062732C Use of compositions based on alpha-pyrones for inducing and stimulating hair growth and/or retarding hair loss
03/06/2001US6197812 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
03/06/2001US6197225 Chromene compound
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 120